Page last updated: 2024-11-05

tizanidine and Carcinoma

tizanidine has been researched along with Carcinoma in 1 studies

tizanidine: RN given refers to parent cpd; structure
tizanidine : 2,1,3-Benzothiadiazole substituted at C-4 by a Delta(1)-imidazolin-2-ylamino group and at C-4 by a chloro group. It is an agonist at alpha2-adrenergic receptor sites.

Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.

Research Excerpts

ExcerptRelevanceReference
"The present study was aimed to prepare nanoparticles of tizanidine hydrochloride using biodegradable polymers and loading them on orodispersible films to obtain a sustained release dissolution profile with improved permeability and further study the cytotoxicity on A549 lung carcinoma cells, MCF7 breast cancer cells, and HOP 92 non-small lung adenocarcinoma cells."4.12Development of Biocompatible Nanoparticles of Tizanidine Hydrochloride in Orodispersible Films: ( Dutt, R; Kaushik, D; Mittal, V; Pandey, P; Rahman, MH; Singh, S; Sinha, S; Thapa, S; Verma, R, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sinha, S1
Thapa, S1
Singh, S1
Dutt, R1
Verma, R1
Pandey, P1
Mittal, V1
Rahman, MH1
Kaushik, D1

Other Studies

1 other study available for tizanidine and Carcinoma

ArticleYear
Development of Biocompatible Nanoparticles of Tizanidine Hydrochloride in Orodispersible Films:
    Current drug delivery, 2022, Volume: 19, Issue:10

    Topics: Animals; Biological Availability; Carcinoma; Clonidine; Drug Delivery Systems; Nanoparticles; Polyme

2022